News

Home News Page 3
- Advertisement -

APPLE

Hemispherx Biopharma Announces IRB Approval of Clinical Study in Metastatic Triple...

The Phase II Study Will Combine Hemispherx’s Ampligen with Keytruda OCALA, Fla., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB), an...

RECENT POSTS